GeneLink Inc. accepted the resignation of Susan Hunt as Interim Chief Financial Officer of the company effective as of February 8, 2013. Ms. Hunt will continue to provide consulting services through the filing of Form 10-K for the year ended December 31, 2012. Bernard L. Kasten, Jr., M.D., the CEO and President will assume the duties of interim CFO until such time as the company hires a replacement CFO.